ResMed designs and sells devices and software for sleep apnea, COPD and other chronic respiratory conditions, including CPAP/APAP machines, masks and connected care platforms. Cloud-linked therapy data and remote monitoring help clinicians and home-care providers manage long-term treatment adherence. The company serves patients, sleep labs, hospitals and durable medical equipment suppliers in major healthcare markets. Its position rests on respiratory device design, digital patient management and a large installed base of connected therapy users.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 1,291.7 | — | 365 | 16.5% |
| Q2 2025 | 1,348 | — | 379.7 | 24.3% |
| Q3 2025 | 1,335.6 | — | 348.5 | 6.2% |
| Q4 2025 | 1,422.8 | — | 392.6 | 10.1% |
| Q1 2026 | 1,431.4 | 10.8% | 398.7 | 9.2% |
| Q2 2026 | 1,463.7 | 8.6% | 383.4 | 1% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Gold Fields Limited (GFI), Iron Mountain Incorporated (IRM), Vulcan Materials Company (VMC), TKO Group Holdings, Inc. (TKO), Shinhan Financial Group Co., Ltd. (SHG), Zoetis Inc. (ZTS)